Form 8-K - Current report:
SEC Accession No. 0001654954-25-003305
Filing Date
2025-03-25
Accepted
2025-03-25 17:29:13
Documents
15
Period of Report
2025-03-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 28532
  Complete submission text file 0001654954-25-003305.txt   173061

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA drma-20250325.xsd EX-101.SCH 6311
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20250325_lab.xml EX-101.LAB 16902
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20250325_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20250325_pre.xml EX-101.PRE 12342
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20250325_def.xml EX-101.DEF 4203
17 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5823
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 25769442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)